---
schema_version: "secwatch.filing_event.v1"
accession: "0000897101-22-000087"
form_type: "8-K"
ticker: "ELMD"
cik: "0001488917"
company_name: "Electromed, Inc."
filed_at: "2022-02-08T23:59:59+00:00"
generated_at: "2026-06-27T10:04:50.253651+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Electromed Q2 revenue record $10.2M (+7.9% YoY); EPS $0.10 vs $0.13

## Summary
- Home care revenue $9.4M (+5.6% YoY); annualized revenue per direct sales rep $951K above target.
- Gross margin 76.9% vs 79.2% due to higher raw material and shipping costs.
- Operating income $1.1M vs $1.6M; net income $0.8M ($0.10 diluted) vs $1.2M ($0.13).
- Cash $10.5M; repurchased 55,687 shares for $663K during quarter.
- CEO cites strategic investments in sales force, marketing, and next-gen SmartVest development.

## SEC filing metadata
- accession: 0000897101-22-000087
- form_type: 8-K
- ticker: ELMD
- cik: 0001488917
- company_name: Electromed, Inc.
- filed_at: 2022-02-08T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1488917/000089710122000087/0000897101-22-000087-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1488917/000089710122000087/elmd220143_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000897101-22-000087
- JSON: https://secwatch.observer/filing/0000897101-22-000087.json
- Plain text: https://secwatch.observer/filing/0000897101-22-000087.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.